Live Research Database
Psoriasis
Hub: Atlanta, GA
Connecting patients in Atlanta with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in Georgia
Available Psoriasis Opportunities
5 RecruitingNCT03816345(Verify)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RECRUITING
Psoriasis
NCT07116967(Verify)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
RECRUITING
Psoriasis
NCT06663332(Verify)
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RECRUITING
Psoriasis
NCT02418442(Verify)
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RECRUITING
Psoriasis
NCT06979453(Verify)
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
RECRUITING
Psoriasis
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Psoriasis research in Atlanta through safe, transparent, and patient-first clinical trials."
Research Hubs in Atlanta
Explore other local breakthroughs
Psoriasis Hubs in GA
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT